CSIMarket
 


Teleflex Incorporated  (TFX)
Other Ticker:  
 

Teleflex Incorporated's Quick Ratio

TFX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the forth quarter 2023, Quick Ratio fell to 0.37 below Teleflex Incorporated average.

Within Medical Equipment & Supplies industry 51 other companies have achieved higher Quick Ratio than Teleflex Incorporated in forth quarter 2023. While Quick Ratio total ranking in the forth quarter 2023 has deteriorated compared to the prior quarter from 352 to 1070.

Explain Quick Ratio?
How much Cash & cash equivalents TFX´s has?
What are TFX´s Current Liabilities?


TFX Quick Ratio (Dec 31 2023)
IV. Quarter
(Oct 01 2023)
III. Quarter
(Jul 02 2023)
II. Quarter
(Apr 02 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities Change 4.34 % -4.18 % -9.01 % -12.27 % -14.5 %
Y / Y Cash & cash equivalent Change -23.69 % 121.9 % -18.6 % -43.4 % -34.39 %
Quick Ratio MRQ 0.37 1.51 0.45 0.46 0.5
TFX's Total Ranking # 1070 # 352 # 2443 # 1521 # 1818
Seq. Current Liabilities Change 3.64 % 5.4 % -3.52 % -0.99 % -4.82 %
Seq. Cash & cash equivalent Change -74.72 % 251.45 % -5.04 % -9.55 % -26.49 %



Quick Ratio forth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 52
Healthcare Sector # 196
Overall Market # 1070


Quick Ratio Statistics
High Average Low
2.72 0.93 0.36
(Oct 01 2017)   (Jun 29 2014)




Financial Statements
Teleflex Incorporated's Current Liabilities $ 607 Millions Visit TFX's Balance sheet
Teleflex Incorporated's Cash & cash equivalent $ 223 Millions Visit TFX's Balance sheet
Source of TFX's Sales Visit TFX's Sales by Geography


Cumulative Teleflex Incorporated's Quick Ratio

TFX's Quick Ratio for the trailling 12 Months

TFX Quick Ratio

(Dec 31 2023)
IV. Quarter
(Oct 01 2023)
III. Quarter
(Jul 02 2023)
II. Quarter
(Apr 02 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities TTM Growth 4.34 % -4.18 % -9.01 % -12.27 % -14.5 %
Y / Y Cash & cash equivalent TTM Growth -23.69 % 121.9 % -18.6 % -43.4 % -34.39 %
Quick Ratio TTM 0.7 0.73 0.52 0.53 0.6
Total Ranking TTM # 588 # 3757 # 2130 # 3973 # 596
Seq. Current Liabilities TTM Growth 3.64 % 5.4 % -3.52 % -0.99 % -4.82 %
Seq. Cash & cash equivalent TTM Growth -74.72 % 251.45 % -5.04 % -9.55 % -26.49 %


On the trailing twelve months basis Due to rise in Current Liabilities in the IV Quarter 2023 to $606.75 millions, cumulative Quick Ratio decreased to 0.7 below the Teleflex Incorporated average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 32 other companies have achieved higher Quick Ratio than Teleflex Incorporated. While Quick Ratio overall ranking has improved so far to 588, from total ranking during the twelve months ending third quarter 2023 at 3757.

Explain Quick Ratio?
How much Cash & cash equivalents TFX´s has?
What are TFX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 33
Healthcare Sector # 119
Within the Market # 588


trailing twelve months Quick Ratio Statistics
High Average Low
1.86 0.77 0.43
(Oct 01 2017)   (March 31, 2015)




Companies with similar Quick Ratio in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Quick RatioDec 31 2023 MRQ Cash & cash equivalentDec 31 2023 MRQ Current Liabilities
Cytosorbents Corporation  0.97 $ 14.131  Millions$ 14.546  Millions
Cadre Holdings Inc   0.92 $ 87.691  Millions$ 95.206  Millions
Embecta Corp   0.91 $ 298.700  Millions$ 326.600  Millions
Medtronic Plc  0.85 $ 8,321.000  Millions$ 9,793.000  Millions
Innovage Holding Corp   0.80 $ 98.771  Millions$ 123.132  Millions
Angiodynamics Inc   0.78 $ 60.896  Millions$ 78.037  Millions
Haemonetics Corporation  0.74 $ 193.978  Millions$ 261.755  Millions
Pro dex Inc   0.71 $ 7.092  Millions$ 9.990  Millions
Establishment Labs Holdings Inc   0.70 $ 40.035  Millions$ 57.150  Millions
Quoin Pharmaceuticals Ltd   0.67 $ 2.401  Millions$ 3.582  Millions
Perspective Therapeutics Inc   0.59 $ 9.238  Millions$ 15.664  Millions
Adm Tronics Unlimited Inc   0.57 $ 0.662  Millions$ 1.168  Millions
Strata Skin Sciences Inc   0.56 $ 6.784  Millions$ 12.174  Millions
Icu Medical Inc  0.53 $ 255.224  Millions$ 481.838  Millions
Prosomnus Inc   0.49 $ 7.063  Millions$ 14.341  Millions
Baxter International Inc   0.49 $ 3,194.000  Millions$ 6,503.000  Millions
Align Technology inc   0.47 $ 972.742  Millions$ 2,066.611  Millions
Msa Safety Incorporated  0.44 $ 146.442  Millions$ 332.818  Millions
Avanos Medical Inc   0.40 $ 87.700  Millions$ 221.800  Millions
American Oncology Network Inc   0.38 $ 63.928  Millions$ 169.045  Millions
National Vision Holdings Inc   0.38 $ 149.896  Millions$ 397.700  Millions
Dexcom Inc   0.37 $ 566.300  Millions$ 1,516.500  Millions
Teleflex Incorporated  0.37 $ 222.848  Millions$ 606.745  Millions
Docgo Inc   0.35 $ 59.286  Millions$ 170.119  Millions
Avinger Inc   0.29 $ 5.275  Millions$ 18.198  Millions
Masimo Corp  0.29 $ 163.000  Millions$ 563.800  Millions
Resmed Inc   0.28 $ 210.247  Millions$ 764.073  Millions
Alcon inc   0.25 $ 1,128.000  Millions$ 4,594.000  Millions
Precision Optics Corporation Inc   0.23 $ 0.987  Millions$ 4.313  Millions
Steris Plc  0.22 $ 195.585  Millions$ 876.983  Millions

Date modified: 2024-02-24T17:17:53+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com